The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic markers for oropharyngeal cancer after docetaxel, 5-FU, and cisplatin induction chemotherapy followed by concurrent chemoradiotherapy.
Sang-Hee Cho
No relevant relationships to disclose
Woo Kyun Bae
No relevant relationships to disclose
Hyun-Jeong Shim
No relevant relationships to disclose
Won-young Choi
No relevant relationships to disclose
Jun-Eul Hwang
No relevant relationships to disclose
Yoo-Duk Choi
No relevant relationships to disclose
Sang-Chul Lim
No relevant relationships to disclose
Ik-Joo Chung
No relevant relationships to disclose